196 related articles for article (PubMed ID: 16140937)
1. Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.
Hayashi M; Fearns C; Eliceiri B; Yang Y; Lee JD
Cancer Res; 2005 Sep; 65(17):7699-706. PubMed ID: 16140937
[TBL] [Abstract][Full Text] [Related]
2. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis.
Pi X; Yan C; Berk BC
Circ Res; 2004 Feb; 94(3):362-9. PubMed ID: 14670836
[TBL] [Abstract][Full Text] [Related]
3. BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha.
Pi X; Garin G; Xie L; Zheng Q; Wei H; Abe J; Yan C; Berk BC
Circ Res; 2005 Jun; 96(11):1145-51. PubMed ID: 15879308
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.
Holopainen T; López-Alpuche V; Zheng W; Heljasvaara R; Jones D; He Y; Tvorogov D; D'Amico G; Wiener Z; Andersson LC; Pihlajaniemi T; Min W; Alitalo K
Cancer Res; 2012 Jul; 72(14):3512-21. PubMed ID: 22593188
[TBL] [Abstract][Full Text] [Related]
5. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
6. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice.
Hayashi M; Lee JD
J Mol Med (Berl); 2004 Dec; 82(12):800-8. PubMed ID: 15517128
[TBL] [Abstract][Full Text] [Related]
7. Undermining the endothelium by ablation of MAPK-MEF2 signaling.
Olson EN
J Clin Invest; 2004 Apr; 113(8):1110-2. PubMed ID: 15085188
[TBL] [Abstract][Full Text] [Related]
8. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
Weskamp G; Mendelson K; Swendeman S; Le Gall S; Ma Y; Lyman S; Hinoki A; Eguchi S; Guaiquil V; Horiuchi K; Blobel CP
Circ Res; 2010 Mar; 106(5):932-40. PubMed ID: 20110534
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts.
Takeishi Y; Abe Ji; Lee JD; Kawakatsu H; Walsh RA; Berk BC
Circ Res; 1999 Dec 3-17; 85(12):1164-72. PubMed ID: 10590243
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.
Hayashi M; Kim SW; Imanaka-Yoshida K; Yoshida T; Abel ED; Eliceiri B; Yang Y; Ulevitch RJ; Lee JD
J Clin Invest; 2004 Apr; 113(8):1138-48. PubMed ID: 15085193
[TBL] [Abstract][Full Text] [Related]
11. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
12. ERK5 and the regulation of endothelial cell function.
Roberts OL; Holmes K; Müller J; Cross DA; Cross MJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1254-9. PubMed ID: 19909257
[TBL] [Abstract][Full Text] [Related]
13. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
Shinohara ET; Geng L; Tan J; Chen H; Shir Y; Edwards E; Halbrook J; Kesicki EA; Kashishian A; Hallahan DE
Cancer Res; 2005 Jun; 65(12):4987-92. PubMed ID: 15958537
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
15. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase.
Abe J; Kusuhara M; Ulevitch RJ; Berk BC; Lee JD
J Biol Chem; 1996 Jul; 271(28):16586-90. PubMed ID: 8663194
[TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation.
Majumder S; Sowden MP; Gerber SA; Thomas T; Christie CK; Mohan A; Yin G; Lord EM; Berk BC; Pang J
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):419-26. PubMed ID: 24265417
[TBL] [Abstract][Full Text] [Related]
17. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
19. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
20. Role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis.
Yoshizumi M; Kyotani Y; Zhao J; Nagayama K; Ito S; Tsuji Y; Ozawa K
J Pharmacol Sci; 2012; 120(4):259-63. PubMed ID: 23165802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
